Adjunctive Therapies in Type 1 Diabetes

Endocrinology and Metabolism Clinics of North America · Published 2026-07-29 · DOI 10.1016/s0889-8529(26)00042-3

Authors (2)

Courtney A. Ackeifi, Viral N. Shah

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ackeifi, C., Shah, V. (2026). Adjunctive Therapies in Type 1 Diabetes. Endocrinology and Metabolism Clinics of North America. https://doi.org/10.1016/s0889-8529(26)00042-3

Related articles

• Clinical Guidance on the Safe Use of Sodium-Glucose Cotransporter Inhibitors in Adults with Type 1 Diabetes · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal
• Emerging Evidence for Cardiorenal Protection with Sodium–Glucose Cotransporter Inhibitors, Glucagon-like peptide-1 Receptor Agonists, and Mineralocorticoid Receptor Blockers in People with Type 1 Diabetes · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal
• Bone Health in Acromegaly · Endocrinology and Metabolism Clinics of North America · 2025 · Same journal
• Thyroid Cancer Update · Endocrinology and Metabolism Clinics of North America · 2025 · Same journal
• Thyrotoxicosis · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal
• Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal
• Diagnosis of Cushing’s Disease · Endocrinology and Metabolism Clinics of North America · 2025 · Same journal
• Approach to the Hypoglycemic Patient · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal
• Clinical Guidance on the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in Adults with Type 1 Diabetes · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal
• Adrenal Disorders in Pregnancy · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal